ASSET PURCHASE AGREEMENT by and between KLEE PHARMACEUTICALS, INC., DEFIANTE FARMACÊUTICA, S.A. and SIGMA-TAU FINANZIARIA S.P.A., (solely for the purpose of Section 6.4, Section 7.8(a), Section 7.8(e) and Section 12.17), on the one hand, and ENZON...Asset Purchase Agreement • November 12th, 2009 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
ASSET PURCHASE AGREEMENT, dated as of November 9, 2009 (this "Agreement"), by and between Klee Pharmaceuticals, Inc., a Delaware corporation ("Klee"), Defiante Farmacêutica, S.A., a company organized under the laws of Portugal ("Defiante" and, together with Klee, the "Purchasing Parties"), and Sigma-Tau Finanziaria S.p.A., an Italian corporation (solely for the purpose of Section 6.4, Section 7.8(a), Section 7.8(e) and Section 12.17) ("Sigma-Tau"), on the one hand, and Enzon Pharmaceuticals, Inc., a Delaware corporation (the "Seller"), on the other hand. Klee, Defiante and the Seller are sometimes referred to herein individually as a "Party" and collectively as the "Parties."
